Top Markets
#1 MowCat MowCat +777.32%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.82%
#3 SIXSEVEN SIXSEVEN +49.97%
#4 Magma Finance Magma Finance +40.57%
#5 MarsCoin MarsCoin +38.87%
#6 Akedo Akedo +38.69%
#7 Cortex Cortex +26.19%
#8 DeXe DeXe +23.56%
#9 OpenEden OpenEden +13.99%
#10 Pons Pons +12.53%
Coin of the day
MowCat MowCat
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Clasificación en acciones #8294
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Precio por acción
$24.37
Capitalización bursátil
$1.30B
Cambio (1 día)
-7.16%
Cambio (1 año)
-
País
US
Comercio Seaport Therapeutics, Inc. Common Stock (SPTX)

Categoría

Healthcare
Ratio P/B de Seaport Therapeutics, Inc. Common Stock (SPTX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Seaport Therapeutics, Inc. Common Stock, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Seaport Therapeutics, Inc. Common Stock desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH